Totaro, R <br/><br/>
Natalizumab treatment in multiple sclerosis patients: a multicenter experience in clinical practice in Italy.  [electronic resource] 

 -  International journal of immunopathology and pharmacology   
 - 147-54 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0394-6320 
<br/><br/><label>Standard No.: </label>10.1177/039463201402700201  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antibodies, Monoclonal, Humanized--adverse effects<br/>Disability Evaluation<br/>Disease Progression<br/>Disease-Free Survival<br/>Female<br/>Humans<br/>Immunosuppressive Agents--adverse effects<br/>Italy<br/>Kaplan-Meier Estimate<br/>Magnetic Resonance Imaging<br/>Male<br/>Middle Aged<br/>Multiple Sclerosis, Relapsing-Remitting--diagnosis<br/>Natalizumab<br/>Product Surveillance, Postmarketing<br/>Time Factors<br/>Treatment Outcome